Massachusetts Eye and Ear
Massachusetts Eye and Ear
Boston, Massachusetts, United States21 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Juvenile Macular Degeneration, Stargardt Disease 1, Stargardt disease, cone-rod dystrophy, eye disorder, hereditary disease, inherited retinal dystrophy, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Not stated | 2026-10-09 | NCT06445322 | |
| Suprachoroidal Administration in Subjects With Metastases to the Choroid | Neoplasms by Site, eye disorder, neoplasm, ocular cancer | Recruiting | Phase 2 | 2026-10-08 | NCT06643884 | |
| An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED | Conjunctival Diseases, Conjunctivitis, Allergic, Hypersensitivity, Immediate, conjunctivitis, eye disorder, immune system disorder | Recruiting | Phase 3 | 2026-10-07 | NCT07519902 | |
| Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Juvenile Macular Degeneration, Stargardt Disease 1, Stargardt disease, cone-rod dystrophy, eye disorder, hereditary disease, inherited retinal dystrophy, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Phase 1 / Phase 2 | 2026-10-07 | NCT06467344 | |
| ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis | eye disorder, retinal degeneration, retinal disorder, retinoschisis | Recruiting | Phase 3 | 2026-09-29 | NCT05878860 | |
| ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty | Corneal Transplant Failure | Recruiting | Phase 2 | 2026-09-21 | NCT06753916 | |
| Subconjunctival Humira for Boston Keratoprosthesis | Chemically-Induced Disorders, Conjunctival Diseases, Drug Eruptions, Drug-Related Side Effects and Adverse Reactions, Erythema, Hypersensitivity, Delayed, Pemphigoid, Benign Mucous Membrane, Skin and Connective Tissue Diseases, Stevens-Johnson syndrome, Stomatognathic Diseases, dermatitis, drug allergy, erythema multiforme, eye disorder, immune system disorder, mouth disorder, ocular cicatricial pemphigoid, skin disorder, stomatitis, vesiculobullous skin disease | Not yet recruiting | Phase 1 | 2026-08-31 | NCT06926478 | |
| An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Graves Ophthalmopathy, Graves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hereditary disease, hyperthyroidism, immune system disorder, thyroid gland disorder | Active, not recruiting | Phase 3 | 2026-08-18 | NCT06625398 | |
| Clarifying the Optimal Application of SLT Therapy Trial | eye disorder, glaucoma, ocular hypertension | Recruiting | Phase 3 | 2026-08-14 | NCT04967989 | |
| A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Uveal Neoplasms, eye disorder, malignant choroid melanoma, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, ocular cancer, primitive neuroectodermal tumor, uveal disorder, uveal melanoma | Active, not recruiting | Phase 3 | 2026-07-31 | NCT06007690 | |
| Rate of Progression in USH2A-related Retinal Degeneration | Usher syndrome type 2A, retinitis pigmentosa 39 | Active, not recruiting | Not stated | 2026-07-23 | NCT03146078 | |
| Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial | eye disorder, glaucoma, ocular hypertension | Recruiting | Not applicable | 2026-07-14 | NCT05924477 | |
| Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene | Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Deaf-Blind Disorders, Deafness, Ear Diseases, Eye Abnormalities, Eye Diseases, Hereditary, Hearing Loss, Sensorineural, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Usher syndrome, Usher syndrome type 2, blindness (disorder), eye disorder, hearing disorder, hearing loss disorder, hereditary disease, inherited retinal dystrophy, nervous system disorder, otorhinolaryngologic disease, retinal degeneration, retinal disorder, retinitis pigmentosa, vision disorder | Active, not recruiting | Phase 2 | 2026-07-09 | NCT06627179 | |
| Extended-release Sodium Oxybate (Lumryz) in Spasmodic Dysphonia and Voice Tremor | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, laryngeal disorder, nervous system disorder, otorhinolaryngologic disease, respiratory system disorder, spasmodic dystonia, voice disorders | Not yet recruiting | Phase 1 | 2026-04-28 | NCT07041203 | |
| A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder, retinitis pigmentosa | Recruiting | Phase 1 / Phase 2 | 2026-04-17 | NCT06891885 | |
| ctDNA in Cutaneous Squamous Cell Carcinoma | Neoplasm, Residual, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, neoplasm, skin disorder, skin neoplasm, skin squamous cell carcinoma | Recruiting | Not stated | 2026-03-30 | NCT06875609 | |
| A Trial of Hydrus Microstent Versus Goniotomy | eye disorder, glaucoma, ocular hypertension, open-angle glaucoma | Recruiting | Not applicable | 2026-03-30 | NCT06289491 | |
| Study of Aspirin in Patients With Vestibular Schwannoma | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ear Diseases, NF2-related schwannomatosis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Otorhinolaryngologic Neoplasms, acoustic neuroma, cranial nerve neoplasm, cranial nerve neuropathy, hereditary disease, hereditary neoplastic syndrome, inherited neurodegenerative disorder, neoplasm, nerve sheath neoplasm, nervous system disorder, neurocutaneous syndrome, neurodegenerative disease, neuroendocrine neoplasm, neurofibroma, neurofibromatosis, neuroma, otorhinolaryngologic disease, peripheral nervous system neoplasm, primitive neuroectodermal tumor, retrocochlear disease, schwannoma, vestibulocochlear nerve disorder | Active, not recruiting | Phase 2 | 2025-12-18 | NCT03079999 | |
| Brain Networks in Dystonia | Dyskinesias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, basal ganglia disorder, blepharospasm-oromandibular dystonia syndrome, brain disorder, central nervous system disorder, craniofacial dystonia, dystonic disorder, focal hand dystonia, laryngeal disorder, movement disorder, nervous system disorder, otorhinolaryngologic disease, respiratory system disorder, spasmodic dystonia, voice disorders | Recruiting | Not stated | 2025-12-08 | NCT03042962 | |
| Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration | Neovascular Age-Related Macular Degeneration (nAMD) | Active, not recruiting | Phase 2 | 2025-10-30 | NCT06116890 | |
| Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Recruiting | Not stated | 2025-05-18 | NCT06744296 |